1099:HKG
Sinopharm Group Co Ltd
15,72Â HK$
arrow_upward
+0,45%(+0,070) 1K
16-okt, 16:08:14 (GMT+8) · HKD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_auto1099 tikeri uchun statistika yaratilmoqda...
Ochish
15,79Â HK$
Yuqori
15,99Â HK$
Past
15,67Â HK$
Bozor kapitali
49,06Â mlrd
Oʻrtacha hajm
4,85Â mln
Hajmi
5,89Â mln
Dividend
5,03%
Choraklik dividendlar
0,20Â HK$
Eks-dividend sanasi
23-iyn, 2026
P/E koeffitsiyenti
5,90
52 haftalik eng yuqori
22,34Â HK$
52 haftalik eng past
14,55Â HK$
Aksiya boʻyicha daromad
2,67Â HK$
Muomaladagi aksiyalar
1,19Â mlrd
Xodimlar soni
90Â ming
Ochish
15,79Â HK$
Yuqori
15,99Â HK$
Past
15,67Â HK$
Bozor kapitali
49,06Â mlrd
Oʻrtacha hajm
4,85Â mln
Hajmi
5,89Â mln
Dividend
5,03%
Choraklik dividendlar
0,20Â HK$
Eks-dividend sanasi
23-iyn, 2026
P/E koeffitsiyenti
5,90
52 haftalik eng yuqori
22,34Â HK$
52 haftalik eng past
14,55Â HK$
Aksiya boʻyicha daromad
2,67Â HK$
Muomaladagi aksiyalar
1,19Â mlrd
Xodimlar soni
90Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
ad-hoc-news.de
·
1 kun oldin
Sinopharm stock sits 7.82 percent below HKD 16.95 target from 14 analysts
Profil
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Sinopharm Group Co Ltd haqida
CEO-
Xodimlar soni90,4Â ming
Asos solingan2003
Bosh ofislar-
SektorHealth care provider
Veb-saytsinopharm.com